홈 카테고리 맞춤형시장조사 국제컨퍼런스 글로벌 파트너 메일링 서비스 회사소개회사소개 Contact Us
English Japaness Chinese
Home > 시장보고서 > 메디컬디바이스 > 의료용 일회용품 > Disposable Syringe Markets
카테고리
메디컬디바이스 (4695)
내시경 (161)
분자영상/조영제 (28)
심혈관장치 (338)
안과기기 (102)
의료용 영상진단장치 (416)
의료용 일회용품 (77)
정형외과 (341)
창상관리 (163)
체외진단장치(IVD) (527)
초음파 (55)
치과기기 (176)
카테터 (239)
핵의료 (76)
헬스케어 IT (314)
환자모니터링 (391)
CT/MRI/X-ray (173)
시장보고서

Disposable Syringe Markets

리서치사 Trimark Publications
발행일 2009년 10월 상품코드 100902
페이지 정보 239 pages
가격
US $ 3,400 ￦ 4,050,400 PDF by E-mail (Single User License)
US $ 6,800 ￦ 8,100,800 PDF By E-mail (Unlimited User License)


영문목차

Abstract

This TriMark Publications report examines the disposable syringe markets as well as the supplies utilized in clinics and by patients directly in their homes to diagnose and monitor disease and to administer medications. This analysis is intended to provide basic market data pertaining to the U.S. and worldwide market segments. Each market segment is analyzed to determine size, growth rates, sales projections and factors influencing growth in the U.S. and internationally. Unit and dollar volume are used to indicate market sizes. Additionally, this review examines industry challenges and potential threats to syringe and needle supplies manufacturers and makes strategic recommendations for boosting market share. The emphasis is on those companies actively developing and marketing products to hospitals, physicians and the general public for medically related uses. The disposable syringe market segments are identified as: 1) total reusable needle and syringe market; 2) total disposable needle and syringe market; 3) prefilled syringes; 4) safety syringes; 5) insulin injector pens; 6) needleless injectors; 7) vaccination injectors; 8) blood collection needles and syringes; 9) hypodermic needles and syringes market; 10) insulin needles and syringes market; 11) specialty needles and syringes market; and 12) needleless injector market.

Methodology

The author of this report has a Ph.D. with over 40 years of consulting experience. He has written over 1,000 articles, and has published four books. The editor holds a Ph.D. and is a retired college professor with vast experience in biochemistry, biotechnology, pharmacology and environmental biology. Company-specific information is obtained mainly from industry trade publications, academic journals, news and research articles, press releases and corporate websites, as well as annual reports for publicly-held firms. Additionally, sources of information include the nongovernmental organizations (NGOs) such as the World Health Organization (WHO) and governmental entities like the U.S. Department of Health and Human Services (HHS) and U.S. federal agencies such as the National Institutes of Health (NIH), the Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC). Where possible and practicable, the most recent data available have been used.

Table of Contents

1. Introduction

  • 1.1 Statement of Report
  • 1.2 About this Report
  • 1.3 Scope of the Report
  • 1.4 Objectives
  • 1.5 Methodology
  • 1.6 Executive Summary

2. Disposable Syringe Markets

  • 2.1 Overview
  • 2.2 Infection Control and Safety
    • 2.2.1 Needlestick Injuries
    • 2.2.2 Availability of Safety Syringes in the U.S. Healthcare Facilities
  • 2.3 Cost of Safety Syringe
  • 2.4 Market Expansion
  • 2.5 Unsafe Injection Practices
  • 2.6 Hospital Consolidations Pressure Companies to Reduce Prices
  • 2.7 Strategic Alliance of Needleless Injector Manufacturers
  • 2.8 Technological Advancements in Disposable Syringes
    • 2.8.1 Reconstitution inside Sterile Syringes
    • 2.8.2 Plungerless Prefilled Syringes
    • 2.8.3 The Disposable UniJect™
  • 2.9 Award Winning Syringes
    • 2.9.1 Episure AutoDetect Epidural Syringe
    • 2.9.2 ConfiDose Disposable Autoinjector
    • 2.9.3 Humatrope Reconstitution Device
    • 2.9.4 Vasceze Plungerless Syringe

3. Disposable Syringe Market Segments

  • 3.1 Overview
    • 3.1.1 World Market for Disposable Syringes
    • 3.1.2 U.S. Market for Disposable Syringes
    • 3.1.3 Disposable Syringe Market in India

4. Insulin Syringes

  • 4.1 Insulin Strengths: U-40 and U-100
  • 4.2 Market for Insulin Pen
  • 4.3 Shelf Life of Insulin Pen Cartridges
  • 4.4 An Update on Insulin Injection Devices
    • 4.4.1 Insulin Injection Devices Currently Available in the U.S.
    • 4.4.2 Disposable Pens
    • 4.4.3 Refillable Pens
    • 4.4.4 Pen Needles
    • 4.4.5 Benefits and Patient Preferences
    • 4.4.6 Disadvantages of Pen Syringes
    • 4.4.7 Insulin Pens and the Hospital Bills
  • 4.5 Insulin Pens for Indian Market from IDC
  • 4.6 Expansion of Facilities for Insulin Pens by Eli Lilly and Rexam
  • 4.7 Major Players in Insulin Pens and Syringes
    • 4.7.1 Sanofi-Aventis
      • 4.7.1.1 Sanofi-Aventis' Business in Diabetes Care Segment
    • 4.7.2 Novo Nordisk
      • 4.7.2.1 Novo Nordisk' s Diabetes Care Business in North America
      • 4.7.2.2 Novo Nordisk' s International Operations
      • 4.7.2.3 Novo Nordisk' s Business in Diabetes Care in Europe
    • 4.7.3 Eli Lilly & Co.
      • 4.7.3.1 Byetta
      • 4.7.3.2 Humulin
      • 4.7.3.3 Humalog

5. Safety Syringes

  • 5.1 Available Safety Syringe Technologies
    • 5.1.1 Retrofitted Syringes
    • 5.1.2 Automatically Retractable Syringes
    • 5.1.3 Manually Retractable Syringes
  • 5.2 Safety Syringe Market
  • 5.3 Drivers of Safety Syringes

6. Prefilled Syringes

  • 6.1 Types of Prefilled Syringes (PFS)
  • 6.2 Market for Prefilled Syringes
  • 6.3 The Rise of Prefilled Syringes
  • 6.4 Needle Safety for Prefilled Syringes
    • 6.4.1 V-OVS NS®
    • 6.4.2 Preventis™
    • 6.4.3 UltraSafe Passive® Delivery System/ERYPROSafe™ and NUFILSafe™
  • 6.5 Sterility Maintenance of Prefilled Syringes
  • 6.6 Compatibility of Drugs with the Components of Prefilled Syringes
  • 6.7 Some of the Drugs Available in Prefilled Syringes
    • 6.7.1 Ovidrel® PreFilled Syringe
    • 6.7.2 Enbrel Prefilled Syringes
    • 6.7.3 Biocon' s Prefilled Safety Syringes
    • 6.7.4 Relistor® Prefilled Syringes
    • 6.7.5 PEGASYS®
    • 6.7.6 Afluria®
    • 6.7.7 Enzira®
    • 6.7.8 FluZone® Prefilled Syringe for Children
    • 6.7.9 Novolin® N FlexPen Prefilled Insulin Syringe
    • 6.7.10 NovoLog® Insulin Prefilled Syringe
    • 6.7.11 GlaxoSmithKline' s Vaccines in Prefilled Syringes
  • 6.8 U.S. Production of Unilife' s Prefilled Syringes
  • 6.9 Some of the Major Providers of Syringe-Prefilling Services and Products
    • 6.9.1 Althea Technologies, Inc.
      • 6.9.1.1 Althea' s Clinical Manufacturing
      • 6.9.1.2 Althea' s Fill/Finish Services
      • 6.9.1.3 Althea' s Contract Manufacturing
    • 6.9.2 Baxter International, Inc.
      • 6.9.2.1 Baxter' s Contract Manufacturing
      • 6.9.2.2 Baxter' s Fill and Finish Capabilities
      • 6.9.2.3 Baxter' s Prefilled Syringes Capability
      • 6.9.2.4 Baxter' s Vials
      • 6.9.2.5 Baxter' s Cartridges
    • 6.9.3 Becton, Dickinson and Company
      • 6.9.3.1 BD' s Prefilled Syringe Services
      • 6.9.3.2 BD Hypak SCF™ Glass Prefillable Syringes
      • 6.9.3.3 BD Sterifill SCF™ Plastic Prefillable Syringe Systems
      • 6.9.3.4 BD Physioject™ Disposable AutoInjector
      • 6.9.3.5 BD™ MicroInfusor™ Automatic Injection System
      • 6.9.3.6 BD™ Liquid Dry Injector Disposable Pen Injector
      • 6.9.3.7 BD™ Pens Customized Self-Injection Systems
      • 6.9.3.8 BD Soluvia™ Prefillable Microinjection System
      • 6.9.3.9 BD Preventis™ Shielding System for Prefilled Syringes
    • 6.9.4 Catalent Pharma Solutions, Inc.
      • 6.9.4.1 The Protector Safety Shield System™
      • 6.9.4.2 The ASI™ Autoinjector and Ultra-Compact ASI Mini™ Autoinjector
    • 6.9.5 Hyaluron Contract Manufacturing (HCM)
      • 6.9.5.1 Hyaluron' s Syringe Filling
    • 6.9.6 Vetter Pharma Fertigung GmbH
  • 6.10 Features of Prefilled Syringes
    • 6.10.1 Dual Chamber Prefilled Syringes

7. Pen Syringes

  • 7.1 Pen Devices for Insulin Delivery
  • 7.2 Technical Advances in Insulin Pens
  • 7.3 Pen Types and Styles
  • 7.4 Prefilled Pens
  • 7.5 Reusable Pens
  • 7.6 Prefilled Autoinjecting Disposable Syringes
  • 7.7 Uniject™ Injection Device

8. Microneedle

  • 8.1 Electronic Mosquito

9. Needle-free Injectors

  • 9.1 Needle-free Delivery of Liquids
  • 9.2 Needle-free Delivery of Solid Formulations
  • 9.3 Needleless Injector from Injex
  • 9.4 Jet Syringe from Injex
  • 9.5 Syrijet
  • 9.6 PenJet
  • 9.7 Needle-free Injector for Human Growth Hormone

10. Needle and Syringe Market Trends

  • 10.1 Market Segments
  • 10.2 Customer Needs
  • 10.3 Competitor Analysis
    • 10.3.1 Automatic Safety Syringes
    • 10.3.2 Manually Locking Safety Syringes
  • 10.4 Third Party Reimbursement
  • 10.5 Regulation
  • 10.6 Drug Discovery Trends
  • 10.7 Demographic Shifts
  • 10.8 Growth in Home Healthcare

11. Technological Developments

  • 11.1 Auto-Disable Syringes
    • 11.1.1 AD Syringes with Needle Retraction/Disposal Feature
    • 11.1.2 AD Syringe with No Needle Retraction Feature
    • 11.1.3 Needlestick Prevention Syringes
    • 11.1.4 Automatic Needlestick Prevention Feature
      • 11.1.4.1 UltraSafe® Passive™ Delivery System
      • 11.1.4.2 Sterimatic Sleeve®
      • 11.1.4.3 K3 Safety Cap
  • 11.2 Manual Needlestick Prevention Feature
    • 11.2.1 Safety Lok™ Syringe
    • 11.2.2 Monoject® Magellan™

12. Business Trends

  • 12.1 Market Drivers
  • 12.2 Market Prospects
  • 12.3 Marketing and Distribution
  • 12.4 Competitive Landscape
  • 12.5 Future Technologies
    • 12.5.1 Glide Solid Dose Injector (SDI™)
    • 12.5.2 BD Physioject™

13. Regulatory Measures

  • 13.1 Safety Syringes in Europe

14. Company Profiles

  • 14.1 Abbott Laboratories
    • 14.1.1 HUMIRA® Prefilled Syringe
    • 14.1.2 HUMIRA® Pen
    • 14.1.3 Precision Sure-Dose® Insulin Syringes
  • 14.2 Albert David Limited
  • 14.3 Alshifa Medical Syringes Manufacturing Company Ltd.
  • 14.4 Althea Technologies, Inc.
  • 14.5 Avitro, Inc.
  • 14.6 Baxter International, Inc.
    • 14.6.1 Baxter' s Medication Delivery
    • 14.6.2 Baxter' s IV Therapies
    • 14.6.3 Baxter' s Global Injectables
    • 14.6.4 Baxter' s Infusion Systems
    • 14.6.5 Baxter' s IV Infusion Pumps and Infusion Sets
    • 14.6.6 Baxter' s Pharma Partnering
  • 14.7 Becton, Dickinson and Company (BD)
    • 14.7.1 BD' s Role in Designing Devices for Safe and Effective Injections and Infusions
    • 14.7.2 BD' s Products
  • 14.8 Boston Scientific Corporation
  • 14.9 B. Braun
    • 14.9.1 The Hospital Care Division
    • 14.9.2 The Aesculap Division
    • 14.9.3 The Out Patient Market (OPM) Division
    • 14.9.4 The B. Braun Avitum Division
    • 14.9.5 B. Braun' s Syringe Products
  • 14.10 Bioject Medical Technologies, Inc.
    • 14.10.1 Biojector® 2000
    • 14.10.2 Drug Reconstitution System
    • 14.10.3 Vitajet®
    • 14.10.4 Cool.click™
    • 14.10.5 SeroJet™
  • 14.11 Catalent Pharma Solutions, Inc.
    • 14.11.1 Catalent' s Oral Technologies Segment
    • 14.11.2 Catalent' s Sterile Technologies Segment
    • 14.11.3 Catalent' s Packaging Services Segment
    • 14.11.4 Catalent' s Manufacturing Capabilities
    • 14.11.5 Catalent' s Employee Strength
    • 14.11.6 Catalent' s Syringes
  • 14.12 C.R. Bard, Inc.
    • 14.12.1 Bard' s Vascular Business
    • 14.12.2 Bard' s Urology Business
    • 14.12.3 Bard' s Oncology Business
    • 14.12.4 Bard' s Business in Surgical Specialties
    • 14.12.5 Bard' s Overseas Expansion
    • 14.12.6 Bard' s Bulb Syringes and Trays
    • 14.12.7 Bard' s Piston Syringes and Trays
  • 14.13 Coeur, Inc.
    • 14.13.1 Angiographic Syringes from Coeur, Inc.
    • 14.13.2 CT Syringes from Coeur, Inc.
  • 14.14 Covidien Ltd.
    • 14.14.1 Covidien' s Medical Devices Segment
    • 14.14.2 Covidien' s R&D
    • 14.14.3 Covidien' s Competitors in Medical Devices
    • 14.14.4 Covidien' s Syringes
  • 14.15 Henke-Sass, Wolf GmbH
    • 14.15.1 Two-Part Disposable Syringes 1-50(60) ml
    • 14.15.2 Three-Part Disposable Syringes 1-30 ml
    • 14.15.3 Disposable Needles HSW FINE-JECT®
  • 14.16 Hindustan Syringes & Medical Devices, Ltd. (HMD)
    • 14.16.1 Insulin Syringes from HMD
    • 14.16.2 HMD' s Single Use Needles
    • 14.16.3 HMD' s Single Use Syringes
  • 14.17 Hi-Tech Medical Products Ltd.
  • 14.18 Hyaluron Contract Manufacturing
    • 14.18.1 HCM' s Major Markets
    • 14.18.2 HCM' s Facility
  • 14.19 International Medication System Ltd.
    • 14.19.1 Delivery Systems from IMS
    • 14.19.2 PCA Products from IMS
    • 14.19.3 Phytonadione Injection USP
    • 14.19.4 Lidocaine HCl Jelly, USP 2% (Preservative-free)
  • 14.20 Life-Shield Products, Inc.
  • 14.21 Merit Medical Systems, Inc.
    • 14.21.1 Merit' s Products
    • 14.21.2 Merit' s Vascular Access Products
    • 14.21.3 Merit' s Business in the U.S.
    • 14.21.4 Merit' s International Business
    • 14.21.5 Merit' s Customers
    • 14.21.6 Merit' s R&D
    • 14.21.7 Merit' s Manufacturing Facilities
  • 14.22 Milestone Scientific
    • 14.22.1 Milestone Scientific' s Product Platform
    • 14.22.2 Milestone Scientific' s Investment in R&D
    • 14.22.3 Milestone Scientific' s Business Performance
  • 14.23 Novo Nordisk A/S
    • 14.23.1 Novo Nordisk' s Business in Diabetes Care Segment
    • 14.23.2 Novo Nordisk' s Modern Insulins, Human Insulins and Insulin-related Products
    • 14.23.3 Novo Nordisk' s Geographic Performance in Diabetes Care Products
    • 14.23.4 Pipeline Progress in Nova Nordisk
    • 14.23.5 Novo Nordisk' s Modern Insulin Portfolio
  • 14.24 Owen Mumford Ltd.
    • 14.24.1 Owen Mumford' s Global Locations
    • 14.24.2 Owen Mumford' s Products
  • 14.25 Plas-Pak Industries, Inc.
    • 14.25.1 Dial-A-Dose® Disposable Veterinary Syringes
    • 14.25.2 Dual Syringe and Dental Syringe from Plas-Pak
    • 14.25.3 Mini Dual Syringe
    • 14.25.4 Manual Dual Syringes
  • 14.26 Retractable Technologies, Inc.
    • 14.26.1 Retractable Technologies' Principal Products
    • 14.26.2 Retractable Technologies' Principal Markets
    • 14.26.3 Retractable Technologies' R&D
    • 14.26.4 Retractable Technologies' VanishPoint Products
  • 14.27 Revolutions Medical Corporation
    • 14.27.1 Rev Vac Safety Syringe
  • 14.28 Safety Syringes, Inc.
    • 14.28.1 Custom Engineering from Safety Syringes, Inc.
    • 14.28.2 Syringe Products from Safety Syringes, Inc.
  • 14.29 Smiths Medical International/Medex, Inc.
    • 14.29.1 Smiths Medical' s Markets
    • 14.29.2 Smiths Medical' s Medication Delivery Segment
    • 14.29.3 Smiths Medical' s Vital Care Segment
    • 14.29.4 Smiths Medical' s Safety Devices Segment
    • 14.29.5 Smiths Medical' s Business Performance
    • 14.29.6 Smiths Medical' s Business Performance on Geographic Basis
    • 14.29.7 Smiths Medical' s R&D
    • 14.29.8 Syringes from Smiths Medicals
  • 14.30 Specialized Health Products International, Inc.
    • 14.30.1 SHPI' s Products and Services
    • 14.30.2 SHPI' s Licensed Products
  • 14.31 Star Syringe Ltd.
    • 14.31.1 Star Alliances
    • 14.31.2 Preoducts from Star Syringe Ltd.
  • 14.32 Terumo' s Medical Corporation
    • 14.32.1 Terumo' s General Hospital Products
    • 14.32.2 Terumo' s Diabetes Care Products
    • 14.32.3 Terumo' s Syringe Products
  • 14.33 UltiMed, Inc.
    • 14.33.1 UltiCare™ Insulin Syringes
    • 14.33.2 UltiCare™ Pen Needles
  • 14.34 Unilife Medical Solutions, Ltd.
    • 14.34.1 Pharmaceutical Market for Unilife' s Prefilled Syringes
    • 14.34.2 Unilife Partnership with Sanofi-Aventis
    • 14.34.3 Unilife' s Licensing Agreement with Sanofi-Aventis
    • 14.34.4 Unilife' s Partnership with Gerresheimer Bunde
    • 14.34.5 Unilife' s Portfolio of Safety Syringes
    • 14.34.6 Unilife' s Prefilled Syringes
    • 14.34.7 Unilife' s Contract Manufacturing Activities
    • 14.34.8 Unilife' s Performance in Syringe Market
  • 14.35 Vetter Pharma-Fertigung GmbH & Co., KG
    • 14.35.1 Vetter Services and Solutions
    • 14.35.2 Dual-Chamber Technology
  • 14.36 Vita Needle Company, Inc.
    • 14.36.1 Disposable Stainless Steel Needle Blunts from Vita Needle
    • 14.36.2 Teflon® Dispensing Needles
    • 14.36.3 Vita Needle' s Polypropylene Needles
    • 14.36.4 Vita Needle' s Taper Tip Needles
  • 14.37 West Pharmaceutical Services, Inc.
    • 14.37.1 West' s Pharmaceutical Systems Segment
    • 14.37.2 West' s Tech Group Segment
    • 14.37.3 West' s R&D Activities
    • 14.37.4 West' s Syringe Products
  • 14.38 Wuxi Yushou Medical Appliances Co., Ltd.
  • 14.39 Ypsomed Holding AG
    • 14.39.1 Ypsomed' s Injection Systems
    • 14.39.2 Ypsomed' s Insulin Delivery Systems
    • 14.39.3 Additional Indication Areas for Pen Systems
    • 14.39.4 Ypsomed' s Innovative Injection Systems at a Glance
    • 14.39.5 Ypsomed' s Complete Product Range for Insulin Suppliers
    • 14.39.6 Ypsomed' s New Dual-Chamber Injecting Systems
    • 14.39.7 Ypsomed' s ServoPen
    • 14.39.8 Growth of Ypsomed' s Pen Needles
    • 14.39.9 Ypsomed' s Performance in 2008/2009
    • 14.39.10 Ypsomed' s R&D
  • 14.40 The Medical House PLC (TMH)
    • 14.40.1 TMH' s Products

Appendix 1: U.S. Healthcare Expenditure Projections, 2008-2018

Appendix 2: Syringe Needle Terminology

Appendix 3: Medication Errors and Syringe Safety

  • Appendix 3.1: Injectable Medication Errors
  • Appendix 3.2: Frequency of Syringe Usage
  • Appendix 3.3: Labeling Injectable Medications
  • Appendix 3.4: Challenges of Labeling
  • Appendix 3.5: Benefits of a Write-On Stripe
  • Appendix 3.6: Nurses Influence on Selection of Sharp Devices
  • Appendix 3.7: Needlestick Injuries
  • Appendix 3.8: Prevention of Needlestick Injuries
  • Appendix 3.9: Protection from Needlestick Injuries

INDEX OF FIGURES

  • Figure 2.1: Principal Causes of Needlestick Injuries
  • Figure 2.2: Availability of Safety Syringes in the U.S. Healthcare Facilities, 2008
  • Figure 3.1: Worldwide Unit Market for Syringes and Needles, 2004-2012
  • Figure 3.2: Global Syringe Market, 2009
  • Figure 3.3: Worldwide Market for Disposable Syringes and Needles, 2004-2012
  • Figure 3.4: U.S. Market for Disposable Syringes and Needles, 2006-2013
  • Figure 3.5: Market Segments of the U.S. Syringe Market, 2009
  • Figure 3.6: E.U. Market for Syringes, Needles and Catheters, 2007 and 2008
  • Figure 3.7: Worldwide Market Share for Hypodermic Syringes, 2009
  • Figure 3.8: Disposable Syringe Market in India, 2008-2012
  • Figure 3.9: Market Share for Disposable Syringes in India, 2008
  • Figure 3.10: Market Share for Disposable Needles in India, 2008
  • Figure 4.1: Market Growth for Insulin Pen, 2007-2014
  • Figure 4.2: Market Growth for Insulin Pens in Europe, 2007-2014
  • Figure 4.3: Global Sales Performance of Sanofi-Aventis' Lantus, 2007 and 2008
  • Figure 4.4: Global Sales Performance of Sanofi-Aventis' Amaryl, 2007 and 2008
  • Figure 4.5: Sales Performance of Sanofi-Aventis' Lantus by Geography, 2008
  • Figure 4.6: Novo Nordisk' s Business Performance in Diabetes Care by Geography, 2008
  • Figure 4.7: Novo Nordisk' s Performance in Diabetes Care, 2004-2008
  • Figure 4.8: Eli Lilly' s Business Performance in Byetta, 2006 and 2007
  • Figure 4.9: Eli Lilly' s Business Performance in Humulin, 2006-2008
  • Figure 4.10: Eli Lilly' s Sales Performance in Humalog, 2006-2008
  • Figure 5.1: Growth of Safety Syringe Market, 2008-2012
  • Figure 6.1: Market Growth for Prefilled Syringes, 2009-2013
  • Figure 6.2: Growth of Prefilled Syringes Market in E.U., 2008-2012
  • Figure 10.1: Breakdown of U.S. Syringe Market, 2009
  • Figure 10.2: U.S. Home Healthcare Products Market, 2007-2012
  • Figure 14.1: Abbott' s Global Business Performance by Country, 2008
  • Figure 14.2: Abbott' s Global Business Performance, 2004-2008
  • Figure 14.3: Baxter' s Performance in Medication Delivery Segment, 2008
  • Figure 14.4: Baxter' s Performance in IV Therapies, 2006-2008
  • Figure 14.5: Baxter' s Performance in Injectables, 2006-2008
  • Figure 14.6: Baxter' s Performance in Infusion Systems, 2006-2008
  • Figure 14.7: BD' s Performance in Safety-engineered Devices, 2007 and 2008
  • Figure 14.8: BD' s International Performance in Safety-engineered Devices, 2007 and 2008
  • Figure 14.9: Business Performance by B. Braun' s Hospital Care Division, 2006-2008
  • Figure 14.10: Business Performance by B. Braun' s Aesculap Division, 2006-2008
  • Figure 14.11: Business Performance by B. Braun' s Out Patient Market Division, 2006-2008
  • Figure 14.12: Business Performance by B. Braun' s Avitum Division, 2006-2008
  • Figure 14.13: B. Braun' s Business Performance by Geographic Region, 2008
  • Figure 14.14: Share of Bioject' s Business with its Prominent Customers, 2007
  • Figure 14.15: Bioject' s Business Performance by Product Line, 2007
  • Figure 14.16: Biotech' s Business Performance in the U.S. and Other Countries, 2007
  • Figure 14.17: Catalent' s Business Performance, 2004-2008
  • Figure 14.18: Catalent' s Business Performance in its Oral Technologies Segment, 2007 and 2008
  • Figure 14.19: Catalent' s Business Performance in its Sterile Technologies Segment, 2007 and 2008
  • Figure 14.20: Catalent' s Business Performance in its Packaging Services Segment, 2007 and 2008
  • Figure 14.21: Catalent' s Employee Strength by Region, 2008
  • Figure 14.22: Bard' s Business Performance in its Vascular Segment, 2004-2008
  • Figure 14.23: Bard' s Business Performance in its Urology Segment, 2004-2008
  • Figure 14.24: Bard' s Business Performance in its Oncology Segment, 2004-2008
  • Figure 14.25: Bard' s Business Performance in its Surgical Specialties Segment, 2004-2008
  • Figure 14.26: Business Performance of Covidien' s Medical Device Segment, 2006-2008
  • Figure 14.27: Covidien' s Investment in R&D, 2006-2008
  • Figure 14.28: Covidien' s Business Performance in Syringes (Sharp Safety Products), 2006-2008
  • Figure 14.29: Merit' s Business Performance, 2004-2008
  • Figure 14.30: Merit' s Investment in R&D, 2004-2008
  • Figure 14.31: Milestone Scientific' s Investment in R&D, 2007 and 2008
  • Figure 14.32: Milestone Scientific' s Domestic Business Performance, 2007 and 2008
  • Figure 14.33: Milestone Scientific' s International Business Performance, 2007 and 2008
  • Figure 14.34: Novo Nordisk' s Sales Performance of Diabetes Care Products, 2004-2008
  • Figure 14.35: Novo Nordisk' s Sales Performance in Modern Insulins (Insulin Analogues), 2004-2008
  • Figure 14.36: Retractable Technologies' Business Performance, 2004-2008
  • Figure 14.37: Retractable Technologies' Domestic Business Performance, 2006-2008
  • Figure 14.38: Retractable Technologies' International Business Performance, 2006-2008
  • Figure 14.39: Retractable Technologies' Investment in Research and Expenditure, 2006-2008
  • Figure 14.40: Smiths Medical' s Business Performance, 2007 and 2008
  • Figure 14.41: Smiths Medical' s Business Performance by Segment, 2007
  • Figure 14.42: SHPI' s Sales Performance, 2006 and 2007
  • Figure 14.43: SHPI' s Revenue from Royalties, 2006 and 2007
  • Figure 14.44: Terumo' s Business Performance in Prefilled Syringes, 2005-2007
  • Figure 14.45: Terumo' s Business Performance in Diabetes Care, 2003-2007
  • Figure 14.46: West' s Business Performance in Pharmaceutical Systems Segment, 2006-2008
  • Figure 14.47: West' s Business Performance in Tech Group Segment, 2006-2008
  • Figure 14.48: West' s Investment in R&D in Pharmaceutical Systems Segment, 2006-2008
  • Figure 14.49: West' s Investment for R&D in Tech Group Segment, 2006-2008
  • Figure 14.50: Global Prevalence of Diabetes, 2008-2025
  • Figure 14.51: Prevalence of Diabetes in India, 2008-2025
  • Figure 14.52: Prevalence of Diabetes in China, 2008-2025
  • Figure 14.53: Ypsomed' s Sales Performance, 2006/2007 and 2008/2009
  • Figure 14.54: Ypsomed' s Sales Performance by Geography, 2008/2009
  • Figure 14.55: Ypsomed' s R&D Expenditure, 2006/2007 and 2008/2009
  • Figure 14.56: TMH' s Business Performance, 2006-2008
  • Figure 14.57: TMH' s Business Performance by Geography, 2008
  • Figure A1.1: National Health Expenditure in the U.S., 2009-2014
  • Figure A1.2: National Health Expenditure as a Percent of GDP, 2009-2014
  • Figure A1.3: Health Expenditure Per Capita, 2009-2014
  • Figure A1.4: Home Healthcare Expenditure, 2009-2014
  • Figure A1.5: Prescription Drug Expenditure, 2009-2014
  • Figure A1.6: Other Non-Durable Medical Products Expenditure, 2009-2014
  • Figure A1.7: Nursing Home Care Expenditure, 2009-2014
  • Figure A1.8: Dental Service Expenditure, 2009-2014
  • Figure A1.9: Hospital Care Expenditure, 2009-2014
  • Figure A1.10: Physician and Clinical Services Expenditure, 2009-2014
  • Figure A1.11: Personal Healthcare Expenditure, 2009-2014
  • Figure A3.1: Timing of Needlestick Injuries

INDEX OF TABLES

  • Table 4.1: Shelf Life of Insulin Pen Cartridges
  • Table 4.2: Major Insulin Pen Devices Currently Available in the U.S., 2008
  • Table 10.1: Highlights of Several Leaders in the Disposable Safety Syringe Market
  • Table 14.1: Albert David' s Syringes with Needles, 2009
  • Table 14.2: Albert David' s Needles, 2009
  • Table 14.3: BD' s Auto-Disable Syringes
  • Table 14.4: Insulin Syringes from BD, 2009
  • Table 14.5: BD' s Allergy Syringes
  • Table 14.6: BD' s Tuberculin Syringes
  • Table 14.7: BD' s Syringes and Needles (Sterile, Single-Use)
  • Table 14.8: BD' s Safety-Lok™ Safety-Syringes
  • Table 14.9: BD' s SafetyGlide Syringes
  • Table 14.10: BD' s Eclipse Syringes
  • Table 14.11: BD' s Integra Syringes
  • Table 14.12: BD' s PosiFlush Prefilled Syringes
  • Table 14.13: Bard' s Piston Syringes and Trays, 2009
  • Table 14.14: Bard' s Bulb Syringes and Trays, 2009
  • Table 14.15: Angiographic Syringes from Coeur, Inc., 2009
  • Table 14.16: CT Syringes from Coeur, Inc., 2009
  • Table 14.17: HMD' s Dispovan Insulin Syringes, 2009
  • Table 14.18: HMD' s Single Use Needles, 2009
  • Table 14.19: HMD' s Single Use Syringes, 2009
  • Table 14.20: Hi-Tech Single-Use Syringes, 2009
  • Table 14.21: Hi-Tech' s Single Use Insulin Syringes, 2009
  • Table 14.22: HCM' s Contract Manufacturing Categories, 2009
  • Table 14.23: Syringes from IMS, 2009
  • Table 14.24: PCA Syringe from IMS, 2009
  • Table 14.25: Phytonadione Injection USP from IMS, 2009
  • Table 14.26: Lidocaine Prefilled Syringes from IMS, 2009
  • Table 14.27: Life-Shield' s Syringe Products, 2008
  • Table 14.28: Autopen Products from Owen Mumford, 2008
  • Table 14.29: Unifine Products from Owen Mumford, 2008
  • Table 14.30: Autoject Products from Owen Mumford, 2008
  • Table 14.31: Retractable Technologies' VanishPoint Syringes, 2009
  • Table 14.32: Smiths' Pro Fixed Needle TB Syringe, 2009
  • Table 14.33: Smiths' Needle-Pro® Needle with Needle Protection Device
  • Table 14.34: Smiths' Needle-Pro® Syringe and Needle with Needle Protection Device, 2009
  • Table 14.35: Smiths' Needle-Pro® Needle Protection Device for Insulin Injections, 2009
  • Table 14.36: Smiths' Needle-Pro® Fixed Needle Insulin Syringe
  • Table 14.37: SurGard2 Syringes with Safety Needle, 2009
  • Table 14.38: Terumo' s SurGuard2 Safety Needles, 2009
  • Table 14.39: Terumo' s Hypodermic Needles, 2009
  • Table 14.40: Terumo' s Hypodermic Syringes without Needle, 2009
  • Table 14.41: Terumo' s Tuberculin Syringes, 2009
  • Table 14.42: Terumo' s Hypodermic Syringes with Needle
  • Table 14.43: Terumo' s SurSaver 1 cc Syringes with Low Dead Space, 2009
  • Table 14.44: Terumo' s Dental Needles, 2009
  • Table 14.45: Terumo' s Spinal Needles, 2009
  • Table 14.46: Terumo' s SurGuard Safety Insulin Syringes, 2009
  • Table 14.47: Terumo' s Insulin Syringes, 2009
  • Table 15.48: Thinpro' s Insulin Syringes, 2009
  • Table 15.49: UltiMed' s UltiCare Insulin Syringes, 2009
  • Table 14.50: UltiCare Pen Needles, 2009
  • Table 14.51: Vita Needle' s Stainless Steel Needle Blunts, 2009
  • Table 14.52: Vita Needle' s Teflon Dispensing Needles, 2009
  • Table 14.53: Vita Needle' s Polypropylene Needles, 2009
  • Table 14.54: Vita Needle' s Taper Tip Needles, 2009
  • Table 14.55: Ypsomed' s Product Roadmap, 2009-2013
  • Table 14.56: Ypsomed' s Innovative Platforms
Back to Top